Saving Lives at Birth: novel microarray patch to treat neonatal sepsis receives international funding

Researchers at Queen’s University Belfast have developed a novel microarray patch to deliver antibiotics for the treatment of neonatal sepsis, a significant cause of childhood mortality that accounts for 26-36% of neonatal deaths globally. The potential of this microarray patch to offer an affordable, less-invasive and user-friendly treatment option was recently recognised by Saving Lives at Birth, a scheme which aims to identify and fund novel, scalable and sustainable solutions to improve infant and maternal health.